CEO Executive AssistantFundraising is an existential activity for development-stage biotechnology companies. Without capital, clinical programs cannot proceed, talent cannot be retained, and scientific platforms cannot be developed. Biotech CEOs spend a substantial portion of their time on fundraising activities, from the initial Series A pitch through subsequent rounds and ultimately to the public offering. Each fundraising round has distinctive logistics, preparation requirements, and stakeholder management demands. The personal assistant who supports a biotech CEO through this cycle provides operational leverage that can meaningfully affect fundraising outcomes.
The Biotech Fundraising Cycle
Most biotechnology companies progress through a series of private financing rounds before accessing public markets. The typical progression involves:
Series A: The initial institutional financing round, often raising $50-150 million to advance a platform from research through early clinical development. Series A investors are typically venture capital firms with life sciences expertise.
Series B and C: Follow-on rounds that fund continued clinical development, often including expansion of the clinical program and preparation for potential partnership discussions. These rounds may include crossover investors with both private and public market investment mandates.
Crossover round: A late-stage private financing round that often includes public market investors (hedge funds and long-only healthcare funds) in addition to existing venture investors, typically in anticipation of an IPO.
IPO: The initial public offering, which provides access to the public capital markets and typically involves a two-week roadshow followed by listing on NASDAQ or NYSE.
Each stage of this cycle has distinctive fundraising logistics that require PA support.
Series A and Venture Capital Fundraising
Series A fundraising involves pitching the company’s scientific platform, leadership team, and development plan to a range of venture capital firms in the hope of identifying lead investors who will commit capital and typically join the board. The CEO conducts many pitch meetings over an extended fundraising period.
The PA manages the logistics of this pitch process, scheduling meetings with target investors, maintaining a tracking system for investor pipeline status (first meeting, follow-up, term sheet discussion), and coordinating the logistics of due diligence meetings with interested investors. The due diligence process for institutional investors may involve site visits, scientific advisory meetings, and management presentations that require coordination.
Data Room Management
All institutional fundraising rounds involve a data room: a secure document repository containing the company’s key business, scientific, clinical, financial, and legal information. Investors conduct their due diligence using data room access, reviewing documents that inform their investment decision.
The PA often manages the data room logistics, including organizing the document structure, coordinating document collection from across the company, managing access permissions for different investor groups, and tracking which documents have been reviewed and which additional information requests have been made.
Data room management requires disciplined organization and careful attention to version control, ensuring that investors are reviewing current documents and that outdated materials are removed promptly.
Investor Meeting Preparation
Before each investor meeting, the CEO needs briefing materials on the investor firm, the specific individuals attending, their investment focus, any prior interactions with the company, and any specific questions or concerns they have raised. Preparing these briefings requires the PA to maintain a comprehensive investor relationship database and to work with the company’s existing investor relationships for context on new investors.
The PA also manages the preparation of pitch materials, working with the scientific, financial, and communications teams to ensure that presentation materials are current, accurately represent the company’s programs, and comply with applicable securities law requirements.
Managing the Roadshow
The IPO roadshow is a concentrated, intensive period of investor meetings that typically covers multiple cities and involves eight to twelve meetings per day for two weeks. Managing the roadshow logistics is one of the most demanding tasks the PA will undertake.
Working with the investment banking team’s roadshow coordinators, the PA manages the CEO’s schedule, travel logistics, hotel accommodations, ground transportation between meetings, and the operational cadence of an exhausting program. The PA also manages the CEO’s communications during the roadshow period, filtering incoming messages and ensuring that internal business issues are managed by the team without requiring CEO intervention.
Existing Investor Relationship Management
Between fundraising rounds, biotech CEOs maintain regular communication with existing investors through formal quarterly updates, board meetings, and informal engagement. The PA manages this ongoing investor communication program, scheduling investor update calls, preparing materials for investor meetings, and ensuring that the CEO’s communications with existing investors are timely and substantive.
Managing existing investor relationships carefully between rounds builds the trust and confidence that facilitates subsequent financing rounds on favorable terms. Investors who feel informed and engaged are more likely to participate in follow-on rounds than those who receive only formal, infrequent communications.
Managing the Confidentiality of Fundraising Activity
Biotech fundraising discussions involve material non-public information for companies with any public company securities outstanding, and even for purely private companies the disclosure of fundraising discussions to the wrong parties can affect the negotiating dynamics. The PA must manage the confidentiality of fundraising activities carefully, ensuring that information about financing discussions is shared only with individuals who need to know.
For public companies conducting private placements or confidentially marketed public offerings (CMPOs), strict confidentiality protocols apply. The PA must understand these protocols and ensure that scheduling and document management practices comply with them.
For context on the full scope of PA responsibilities in life sciences executive support, see pharma PA duties. The pharma CEO assistant guide provides essential background on supporting biotech and pharma executives.
Conclusion
Fundraising is the financial lifeblood of development-stage biotech companies, and the CEO’s ability to manage the fundraising process effectively, while simultaneously advancing the scientific and clinical programs that make the investment case, is a defining test of biotech leadership. The personal assistant who manages the logistics of investor meetings, data rooms, and roadshow travel with precision, while ensuring that the CEO has the preparation support needed for each investor interaction, contributes directly to outcomes that determine whether the company can continue to develop its programs toward patients.
Related Reading
For further context, explore Personal Assistant for 3PL CEO Third Party Logistics: Operational Support for a High-Volume Industry and Personal Assistant for Abrasive Manufacturer CEO.